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Biocompatibility of bicarbonate buffered peritoneal dialysis fluids:
Influence on mesothelial cell and neutrophil function. The present study
compares the effects of lactate and bicarbonate buffered PDF on human
neutrophil (PMN) and human peritoneal mesothelial cell (HPMC) viabil-
ity and function. Acute exposure of PMN to lactate buffered PDF at pH
5.5 (CAPD 2, 1.5% and CAPD 3, 4.25% glucose) resulted in significant
reductions in cellular ATP levels, the phagocytosis of serum treated
zymosan (STZ) and respiratory burst activation (CL). Exposure of PMN
to bicarbonate buffered PDF (BIC 20, 1.5% glucose and BIC 30, 4.25%
glucose both at pH 7.2) had no significant effect on cell viability or the CL
response. Phagocytosis was, however, depressed significantly more follow-
ing exposure to BIC 30 than BIC 20. PMN cellular ATP levels and
phagocytosis were significantly better in cells exposed to BIC 30 than to
CAPD 3 at pH 7.4 (P = 0.043 for both). Pre-exposure of HPMC to CAPD
2, CAPD 3 or BIC 30 for 30 minutes resulted in a significant reduction in
cellular ATP content compared to control medium. Pre-exposure to BIC
20 did not result in a reduction in HPMC ATP levels. HPMC synthesis of
IL-6 was unaffected by 15 or 30 minutes pre-exposure to BIC 20 or BIC 30,
in contrast pre-exposure to CAPD 2 or CAFD 3 for 15 or 30 minutes
resulted in a significant reduction in stimulated IL-6 synthesis (24.5 3.01
and 32.3 5.0vs. 43.9 10 pg/.rg cell protein in M199, N 6; P = 0.02).
Neutralization of the pH of CAPD 2 and CAPD 3 resulted in normaliza-
tion of HPMC JL-6 secretion. Analysis of IL-6 mRNA expression in
control, BIC 20 and 30 pre-treated HPMC subsequently stimulated with
IL-1 revealed no differences in the expression of the IL-6 specific 465
base pair transcripts. The improved cellular function in bicarbonate
buffered PDF indicates potentially improved host defence status and
preservation of the peritoneal membrane in CAPD patients.
Peritoneal dialysis has been used as a therapy for end-stage
renal failure for more than twenty years. During this period
significant advances have been made in reducing the rate of
infection, mainly as a result of improvements in delivery systems
[1, 2]. During this same period, however, despite significant
evidence to indicate its bioincompatibility, the almost exclusive
use of lactate-buffered peritoneal dialysis fluid (PDF) has contin-
ued. Only relatively recently have alternative dialysis fluids be-
come available for clinical trials.
It is now well established that lactate-buffered peritoneal dial-
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ysis fluids (PDF) modulate leukocyte and mesothelial cell func-
tions both in vitro and in vivo [reviewed in 3]. The effects are
manifestly the result of its unphysiological composition. These
inhibitory phenomena are well characterized and include the
combined effects of low pH and lactate, hyperosmolality and
glucose concentration per se, as well as breakdown products
resulting from the heat sterilization procedure [3—11].
Since it is clear that lactate buffered PDF possesses an inhibi-
tory capacity related both directly and indirectly to its manufac-
ture (low pH and glucose breakdown products), its buffer (lactate)
and to its osmotic agent (glucose), the re-design of fluids has been
considered necessary. The aim has been to modify or eliminate
some of these inhibitory factors. Numerous in vitro biocompatibil-
ity studies have been performed with alternative lactate buffered
PDF, containing histidine to neutralize the initial pH of the fluid
[12], with glucose polymer as an alternative iso-osmolar osmotic
agent to replace glucose [13, 14], and most recently with bicar-
bonate buffered PDF to create a pH neutral fluid and remove
lactate altogether [15].
The present study evaluates the in vitro biocompatibility profile
of a newly formulated bicarbonate buffered PDF using human
peritoneal mesothelial cells (HPMC) and human neutrophils
(PM N) as the target cells. Our data demonstrate improved
HPMC and PMN function following acute exposure to bicarbon-
ate fluids when compared to lactate buffered PDF. These findings
suggest that host defence and the function of the mesothelium
may be better maintained in bicarbonate PDF, thus potentially
prolonging the life of the peritoneal membrane as a dialyzing
organ.
Methods
All chemicals, unless otherwise stated, were obtained from the
Sigma Chemical Company (Poole, Dorset, UK). Recombinant
human IL-1f3 was a kind gift from Dr. D. Boraschi (Sclavo
Research Centre, Sienna, Italy). Its specific activity was 2.5 X io
U/mg as assessed in the EL-416/CTLL bioassay. All cytokine
preparations were sterile filtered, batched, stored at —70°C and
freshly thawed for each experiment. Endotoxin contamination of
recombinant material was < 0.7 pg/pg protein as assessed by
limulus amoebocyte lysate assay (Kabi Vitrum, Stockholm, Swe-
den).
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Table 1. Composition of PDF
CAPD2 Bic 20 CAPD 3 Bic 30
Na mmol/liter 134 134 134 134
C1 mmol/liter 103.5 104.5 103.5 104.5
Ca2 mmol/liter 1.75 1.75 1.75 1.75
Mg2 mmol/liter 0.5 0.5 0.5 0.5
Lactate mmol/liter 35 — 35 —
HC03 mmol/liter — 34 — 34
Glucose monohydrate glliter 15 15 43.5 43.5
pH 5.5 7.4 5.5 7.4
Osmolality mOsmol/kg 358 358 512 511
Test fluids
All PDF were obtained from Fresenius AG (Bad Homburg,
Germany); their formulations are described in Table 1. The
bicarbonate solutions were supplied as a double chamber bag
system. Immediately prior to use a frangible seal separating the
two chambers was broken and the fluids mixed thoroughly. Fresh
PDF, pre-warmed to 37°C, were used for each experiment. In
order to confirm that the pH of the bicarbonate dialysis fluids was
stable over the time course of the experiments, both BIC 20 and
BIC 30 were incubated at 37°C, over a four hour period, in a 5%
CO2 atmosphere. Under these conditions the pH of BIC 20 rose
from 7.38 0.15 at time zero to 7.6 0.13 after 240 minutes. The
pH of BIC 30 under these conditions increased from 7.11 0.11
at time zero to 7.3 0.14 after 240 minutes (N = 3 experiments
for both).
Preparation of PMN
Human PMN were prepared from the citrated peripheral blood
of healthy volunteers by dextran sedimentation and Ficoll-
Hypaque density gradient centrifugation as described previously
[9]. The polymorphonuclear cell fraction routinely contained >
95% PMN as assessed by light microscopy of stained preparations
(Neat Stain; Guest Medical Ltd, Sevenoaks, UK).
Serum treated zymosan (STZ)
Boiled zymosan (Sigma; 40 mg) was incubated with 75% vol/vol
pooled normal human serum in KRPG for 30 minutes at 37°C,
washed three times with KRPG and resuspended to 4 ml. A stock
solution of 10 mg/mI concentration was aliquoted and stored at
—70°C. Freshly thawed aliquots of this same STZ preparation
were used in all PMN stimulation experiments.
PMN viability (measurement of total cellular A TP)
Five million PMN were incubated in 5 ml of the test fluids for
30 minutes at 37°C with constant tube rotation. The PMN were
centrifuged (150 X g), washed X 3 and resuspended to 1 X 106/ml.
One hundred thousand PMN were extracted for measurement of
total cellular ATP using a modification of the method previously
described [16—18]. Briefly, 250 j.tl of 1 mg/mI benzylkonium
chloride in 10 mrvi EDTA (both from Sigma) was added to the
PMN suspension to extract ATP. Subsequently, 250 tl of 25 mM
HEPES/lO mi EDTA was added to stabilize the extracted ATP.
The ATP content was measured by adding 25 1.d firefly biolumi-
nescence reagent (ATP Bioluminescence CLS reagent; Boehr-
inger Mannheim, Germany) to 25 j.d of extracted sample and
placed in a Lumac/3M Biocounter M2010 (Lumac, Landgraaf,
The Netherlands). Under the conditions used there was a direct
correlation between relative light units (RLU) generated and
ATP concentration determined using the internal ATP standard
supplied (y = 13610x°472, r = 0.992).
Phagocytosis
One milliliter of a PMN suspension (2 X 106) was plated in 35
mm petri dishes (Gibco/BRL Life Technologies Ltd) in RPMI
containing 0.2% wt/vol bovine serum albumin (RPMI-BSA) (ICN
Biomedicals Ltd, High Wycombe, UK). The PMN were allowed
to adhere for 30 minutes at 37°C in a 5% CO2/95% air humidified
incubator, washed three times with phosphate buffered saline, pH
7.3 (PBS; Oxoid Ltd, Basingstoke, UK) and incubated for 40
minutes at 37°C in the presence of the fluids to be tested (1 ml)
containing 100 j.d of STZ (1 mg/ml). The zymosan containing
plates were then washed three times with PBS, air dried, fixed with
methanol, stained (Neat Stain; Guest Medical Ltd) and examined
microscopically. The number of PMN ingesting two or more
particles was assessed by counting 200 cells per plate and the
results expressed as a percentage phagocytosis.
Chemiluminescence assay
PMN (100 l at a concentration of 5.0 x 107/ml) were
incubated with 5 ml of the dialysate fluid to be tested for 30
minutes at 37°C, with constant tube rotation. The cells were
subsequently washed three times with PBS, pH 7.3, recounted and
resuspended to 1.0 x 106/ml. Luminol dependent chemilumines-
cence (CL) was measured using the Berthold LB950-T automatic
luminescence analyzer (Berthold Instruments UK, Ltd, St Albans,
UK) at 37°C. Samples for CL assays contained 200 p1 KRPG, 200
pI PMN and 100 p1 10 j.LM luminol (5-amino 2,3 dihydro 1,4
thalazine dione; Sigma). All samples were pre-incubated at 37°C
for six minutes prior to the addition of zymosan (1.0 mg/ml) in
order to achieve temperature equilibration and to record back-
ground CL. STZ in a volume of 100 p1 in KRPG was added to the
cuvettes and CL measured sequentially over 40 minutes. The area
under the CL curve was integrated and expressed as total counts.
Measurement of intracellular pH [pH]
Cytoplasmic pH [pH]1 of PMN exposed to various test fluids
was estimated fluorimetrically using the probe 2,7-biscarboxy-
ethyl-S [61-carboxyfluoroscein (BCECF; Sigma Chemical Co. Ltd)
as described previously [91. Using ratio excitation wavelengths at
504 nm and 460 nm, emissions were detected at 535 nm and
recorded using a dual wavelength spectrophotometer (Spex CM,
Instruments SA, Stanmore, UK). [pH]1 was subsequently calcu-
lated from knowledge of the pKa of the indicator. Prior to the
experiment PDF (at 37°C) was added to the cuvette and stirred
gently, and PMN pre-loaded with BCECF (10 pI in PBS) were
subsequently added and p[H]1 assessed over a 200 second period.
As a result of the mechanics of the system the first measurement
was taken 10 to 20 seconds after addition of the PMN to allow
thorough mixing of the cells in the fluid.
Bacterial growth experiments
Peritonitis isolates of Staphylococcus aureus and Staphylococcus
epidermidis were cultured overnight in pooled spent dialysate,
centrifuged (3000 >( g), washed x3 in PBS and resuspended to an
optical density of 1.0 at 560 nm (O.D.560 = 1.0). One hundred
microliters of this suspension were inoculated into 40 ml of the
test solutions and incubated at 37°C for 18 hours. At this time
Topley et al: Cell Jhnction in bicarbonate dialysis fluids 1449
point bacterial survival was assessed by serial spread plate analy-
sis.
Isolation and culture of human peritoneal mesothelial cells
Human peritoneal mesothelial cells (HPMC) were obtained
from the omental tissue of consenting patients undergoing elec-
tive abdominal surgery. The cells were isolated and characterized
as described previously 19—21]. HPMC were maintained in
Earle's buffered Medium 199 (Sera Lab/JRH Biosciences Ltd,
Crawley, UK) supplemented with penicillin (100 U/ml), strepto-
mycin (100 .tg/ml), L-glutamine (2 mM; Gibco BRL Life Tech-
nologies Ltd, Uxbridge, UK), transferrin (5 g/ml), insulin (5
jg/ml), hydrocortisone (0.4 jg/ml; all from Sigma) and 10%
vol/vol fetal calf serum (FCS) (Sera Lab Ltd). HPMC cultures
were incubated at 37°C in a humidified 5% CO2 atmosphere.
All data presented are from experiments performed with cells
from the second passage that had previously been growth ar-
rested.
Establishment of growth arrested HPMC
HPMC were grown to confluence in 250 ml flasks or in 24-well
plates (Falcon; Becton-Dickinson UK Ltd, Oxford, UK) and then
transferred to culture medium containing 0.1% vol/vol FCS (rest
medium) for 48 hours prior to stimulation. Previous experiments
had demonstrated that at this time point the cells were maintained
in a viable (as assessed by the lack of LDH release and constant
cellular ATP levels) but non-proliferative state. Under these
conditions the cells could be maintained for up to 120 hours
without any significant loss of viability [22].
Effect of unused PDF on HPMC Jlrnction
HPMC monolayers were grown to confluence in 24-well plates
and growth arrested for 48 hours as previously described. Then
they were washed x 3 with culture medium (0.1% FCS) and
exposed either to control culture medium (M199), CAPD 2,
CAPD 3 (at pH 5.5 or pH 7.3), BIC 20 or BIC 30 all supplemented
with 0.1% vol/vol FCS. CAPD 2 and CAPD 3 were at pH 5.2 or
adjusted to 7.3 with 0.1 M sodium bicarbonate (BDH Chemicals,
Poole, Dorset, UK). Following specified time intervals at 15 and
30 minutes (treatment phase), fluids were removed and replaced
by fresh medium (M199) containing 0.1% vol/vol FCS in which
HPMC were incubated for the next 12 hours (recovery phase) in
the presence or absence of IL-1f3 (10 ng/ml). Thereafter HPMC
supernatants were removed, centrifuged at 12,000 X g and then
stored at —70°C until assayed. At the end of the recovery period
the cells were washed with PBS (pH 7.3) (Dulbecco; Oxoid Ltd,
Basingstoke, UK) and the cellular protein solubilized with 0.1 N
NaOH. Total cellular protein was estimated in these supernatants
using the modified Bradford method [231.
IL-6 production measurements
Constitutive and cytokine stimulated IL-6 release was deter-
mined in the culture supernatants using specific sandwich-ELISA
as previously described [24].
Assay of cellular ATP
HPMC were grown to confluence in 24 well plates, growth
arrested and exposed to control medium, CAPD 2, CAPD 3, BIC
20 or BIC 30 (all containing 0.1% FCS) for 15 minutes at 37°C.
The cells were subsequently washed X3 and allowed to recover in
Table 2. Sequences of the amplification primers
Product
Gene Primers size Reference
IL-6 5'-TACATCCCTCGACGGATCTC-3'
5'-GCTACAmGCCGAAGAGCC-3'
465
[27]
a-Actin 5'-GGAGCAATGATCTITGATCTIT-3'
5'-CCTFCCTGGGCATGGAGTCCT-3'
204
[26, 281
control medium (containing 1.0% FCS) for four hours at 37°C.
Following the initial exposure period and after 30, 60, 120, 180
and 240 minutes "recovery periods" total cellular ATP was
extracted and measured in control and PDF exposed HPMC as
previously described [211.
RNA isolation, reverse transcription (RT) and PCR amplification
HPMC were grown to confluence in 25 cm2 flasks (Falcon,
Beckton-Dickinson), growth arrested and exposed to control
medium, BIC 20 or BIC 30 (all containing 0.1% FCS) for 15
minutes at 37°C. The cells were subsequently washed in culture
medium and allowed to recover in culture medium in the presence
of IL-113 (10 ng/ml) for two hours at 37°C. At defined time periods
total cellular RNA was extracted from both control and PDF
treated HPMC following lysis with 4 M guanidine isothiocyanate
and centrifugation through 5.7 M caesium chloride in 0.1 M EDTA
[25]. Total RNA was reverse transcribed into cDNA with M-
MLVTM reverse transcriptase (Life Technologies Ltd, Paisley,
UK), using the random hexamers method as previously described
[20, 261. PCR was performed for various cycles [25—30]. One-tenth
of the PCR reaction from both test (IL-6) and control (a-actin)
product were mixed and separated by flat bed electrophoresis in
1.5% wt/vol NuSieve GTG agarose gels (Flowgen Instruments
Ltd, Sittingbourne, UK), stained with ethidium bromide (Sigma)
and photographed. The negatives were scanned using a densitom-
eter (Model 620 video densitometer, Bio-Rad Laboratories Ltd)
and the density of the bands compared to those of the housekeep-
ing gene.
Oligonucleotide synthesis
The sequences of the amplification primers are in Table 2.
Statistics
All experiments were performed with PMN from at least five
separate donors or on HPMC prepared from at least five different
omental specimens. All statistical analyses were performed using
the Wilcoxon matched-pairs signed ranks test (Statview 512+
Apple Macintosh mc, Cupertino, CA, USA), a P value of less than
0.05 being considered as significant. All data are presented as
mean (± SEM).
Results
PMN viability: Cellular A TP levels
Exposure of PMN to CAPD 2 or CAPD 3 for 30 minutes
resulted in a significant reduction in cellular ATP levels (45.9
3.94% and 31.25 3.03% of control, respectively; N 5, z =
2.023, P = 0.043 vs. control for both). The reduction in PMN ATP
facilitated by CAPD 3 was, however, significantly greater than that
induced by CAPD 2 (N = 5, z = 2.023, P = 0.043). Following
adjustment of the pH of CAPD 2 or CAPD 3 to 7.3 there was no
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Fig. 1. Effect of pre-exposure to lactate buffered PDF, CAPD 2, (C2), CAPD
3 (C3) and bicarbonate buffered PDF, BIC 20 and BIC 30 on PMN ATP
levels. Data are presented as the mean (± SEM) from 6 experiments with
PMN isolated from separate donors. P < 0.02 versus control, * *P < 0.02
versus BIC 20, < 0.02 versus BIC 30, < 0.05 versus CAPD 3,
pH 7.3.
significant reduction in PMN ATP levels compared to control
medium. Exposure of PMN to BIC 20 or BIC 30 had no effect on
PMN ATP levels (Fig. 1). When PMN ATP levels were compared
in PMN exposed to bicarbonate or lactate buffered PDF at neutral
pH, there was no differences in fluids containing 1.5% glucose. In
contrast, PMN ATP levels were significantly higher in bicarbonate
exposed than lacate exposed PMN in the presence of 4.5%
glucose (N = 5, z = 2.023, P 0.043).
PMN chemiluminescence
Pre-exposure of PMN to CAPD 2 or CAPD 3 resulted in
significant suppression of the respiratory burst, measured as
luminol dependent chemiluminescence. Thirty minutes exposure
reduced STZ induced CL to 40.4 16.6% and 0.47 0.07% of
control levels for CAPD 2 and CAPD 3, respectively (N = 5, z =
2.023, P = 0.043 for both). Pre-exposure of PMN to CAPD 3
caused significantly more suppression of CL than did pre-expo-
sure to CAPD 2 (N = 5, z = 2.023, P = 0.043). Pre-exposure to
BIC 20, BIC 30 or pH adjusted CAPD 2 and 3 did not suppress
the PMN CL response induced by STZ (Fig. 2). There was no
difference in PMN CL between BIC 20 and CAPD 2 at pH 7.3 or
between BIC 30 and CAPD at pH 7.3.
PMN phagocytosis
The phagocytosis of STZ was suppressed in all fluids tested
compared to Ml 99 control (Fig. 3). Following exposure to CAPD
2 and CAPD 3 phagocytosis of STZ was significantly reduced to
31.32 5.3 and 12.8 3.5% of control, respectively (N = 5, z =
2.023, P = 0.043 for both). Phagocytosis in CAPD 3 (pH 5.5 or
7.3) was always significantly lower than in the parallel CAPD 2
fluids. Following exposure to BIC 20 or in CAPD 2 with the pH
adjusted to 7.3 phagocytosis was significantly improved compared
to CAPD 2 pH 5.5. Exposure to BIC 30 (36.41 5.97%) or pH
neutral CAPD 3 (25.19 6.06%) significantly improved phago-
cytosis compared to CAPD 3 pH 5.5 (N = 5, P = 0.043; Fig. 3).
When PMN phagocytosis was compared in PMN exposed to
bicarbonate or lactate buffered PDF at neutral pH, there was no
differences in fluids containing 1.5% glucose. In contrast, PMN
phagocytosis was significantly higher in bicarbonate exposed than
Fig. 2. Effect ofpre-exposure to lactate buffered PDF, CAPD 2, (C2), CAPD
3 (C3) and bicarbonate buffered PDF, BIC 20 and BIC 30 on the subsequent
ability of PMN to mount a respiratoty burst assessed as luminol dependent
CL in response to STZ. Data are presented as the mean (± SEM) from 6
experiments with PMN isolated from separate donors. p < 0.02 versus
control, < 0.02 versus BIC 20, < 0.02 versus BIC 30.
Fig. 3. Effect of exposure to lactate buffered PDF, CAPD 2, (C2), CAPD 3
(C3) and bicarbonate buffered PDF, BIC 20 and BIC 30 on the ability of
PMN to phagocytose STZ. Data are presented as the mean (± suM) from
6 experiments with PMN isolated from separate donors. *p < 0.02 versus
control, < 0.02 versus BIC 20, °°P < 0.02 versus BIC 30, ****p <
0.05 versus CAPD 3, pH 7.3.
lacate exposed PMN in the presence of 4.5% glucose (N =5, z =
2.023, P = 0.043).
PMN JpHJ,
Exposure of PMN to CAPD 2 or CAPD 3 resulted in a rapid
lowering of intracellular pH. Exposure to BIC 20, BIC 30 or
CAPD 2 and CAPD 3 with the pH adjusted to 7.3 resulted in an
initial slight fall in [pH1 and subsequent cytoplasmic alkaliniza-
tion (Fig. 4).
Bacterial survival
Test solutions were inoculated with io cfu/ml of S. aureus or S.
epideimidis and cultured overnight at 37°C. All dialysis fluids
significantly reduced the viable counts of both organisms by
greater than 99%. There were no differences in bacterial survival
between lactate or bicarbonate buffered PDF irrespective of
glucose content (Fig. 5).
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Time, seconds
Fig. 4. Effect of lactate buffered PDF, CAPD 2, CAPD 3 (at pH 5.5 andpH
7.3) and bicarbonate buffered PDF, BIC 20 and BIC 30 on PMN [pH/i. Data
are presented from a single representative experiment of three performed
with PMN from separate donors. Symbols are: (—s—) CAPD 3, pH 7.3;
(—+—) CAPD 2, pH 7.3; (_\7_)BIC 20, pH 7.3; (—c—) BIC 30, pH 7.3;
(—E—) CAPD 2, pH 5.5; (—0—) CAPD 3, pH 5.5.
HPMC viability following PDF exposure
Pre-exposure of HPMC to CAPD 2 for 30 minutes resulted in
a significant reduction in total ATP content. Total cellular ATP
was reduced from 3.47 0.32 pmol/g cell protein in the paired
control (M199+ 0.1% FCS) to 1.17 0.11 pmol/.tg cell protein
(66.23% inhibition; N = 5, z = 1.96; P = 0.04). After 15 minutes
"recovery" total cellular ATP remained significantly lower than
control (3.33 1.2 vs. 1.61 0.25 pmol/tg cell protein (53.82%
inhibition; N = 5, z = 1.96; P = 0.04) for control and CAPD 2
treated cells, respectively. Following an extended recovery period
(30 to 240 mm) cellular ATP levels returned to those of the
control in CAPD 2 treated HPMC (Fig. 6A).
In contrast, exposure of HPMC to BIC 20 for 30 minutes did
not result in a significant alteration in cellular ATP levels com-
pared to control, but were significantly higher than the corre-
sponding cells exposed to CAPD 2 following pretreatment and
during the first 15 minutes of the recovery phase (Fig. 6A).
Thereafter there was no difference between control, BIC 20 or
CAPD 2 treated HPMC.
BIC 30 versus CAPD 3
Exposure of HPMC for 30 minutes to either CAPD 3 or BIC 30
resulted in a significant decrease in total cellular ATP levels. ATP
levels were reduced from 6.8 0.96 pmol/jsg cell protein in
control cells to 0.37 0.13 and 1.87 0.13 pmol/jsg cell protein
for CAPD 3 and BIC 30 pre-treated cells, respectively (N =5, z =
1.96; P = 0.04 vs. control for both). Cellular ATP levels were,
however, significantly higher following exposure to BIC 30 com-
pared to CAPD 3 (94.56 and 72.8% inhibition, N = 5, z = 1.96;
P = 0.04 for both; Fig. 6B).
Following 15 minutes in vitro recovery HPMC ATP levels
250 remained lowered (2.29 0,25 and 2.69 0.8 pmol/g cell
protein for CAPD 3 and BIC 30 pre-treated cells, respectively
(66.54 and 60.69% inhibition, N = 5, z = 1.96; P = 0.04 for both).
Longer recovery periods (30 to 240 mm) resulted in ATP levels
returning to those in the controls for both CAPD 3 and BIC 30
pre-treated HPMC (Fig. 6B).
BIC 20 versus BIC 30
At all time points measured during acute exposure and recovery
periods, HPMC ATP levels were significantly lower in cells
exposed to BIC 30 than those exposed to BIC 20 (N = 6, z =
2.023, P < 0.02 for all time points; Fig. 6C).
HPMC IL-6 synthesis following PDF exposure
BIC 20 versus CAPD 2. Unstimulated growth arrested HPMC
synthesized IL-6 constitutively; after 24 hours it reached 6.43
1.41 pg/sg cell protein (N = 6, z = 2.023, P < 0.02 vs. time zero).
Under the same conditions stimulation of HPMC with IL-lp (10
ng/ml) resulted in a significant increase in IL-6 release, which
reached 43.9 10.07 pg/sg cell protein after 24 hours stimulation
(N = 6, z = 2.023; P < 0.02 vs. unstimulated control).
Pre-exposure of HPMC to CAPD 2 (pH 5.5) resulted in a
significant inhibition of subsequent IL-1/3 stimulated IL-6 release
(after an 18 hr recovery phase). After 15 minutes of exposure to
CAPD 2, IL-6 synthesis was reduced to 24.58 3.01 pg/j.g cell
protein (43.63% inhibition, N = 6, z = 2.023; P < 0.02 vs.
stimulated control). Increasing the pre-exposure period to 30
minutes marginally increased this inhibitory effect (23.36 2.52
pg/jsg cell protein, 46.79% inhibition, N = 6, z = 2.023; P < 0.02
vs. stimulated control; Fig. 7A).
Exposure of HPMC to BIC 20 or CAPD 2 at pH 7.3 resulted in
a normalization of HPMC stimulated IL-6 synthesis. After 15 and
30 minute pre-exposure periods, IL-6 releases were 42.77 3.33
and 35.13 3.78 for BIC 20, and 48.85 2.82 and 39.94 4.02
for CAPD pH 7.3 (pg!ig cell protein, respectively; N = 6, z =
2.023; P < 0.02 vs. CAPD 2, pH 5.5 for all; Fig. 7A).
BIC 30 versus CAPD 3. Pre-exposure of HPMC to CAPD 3 (pH
5.5) resulted in a significant inhibition of subsequent IL-1f3
stimulated IL-6 release (after an 18 hr recovery phase). After 15
minutes exposure to CAPD 3, IL-6 synthesis was reduced to 32.3
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Fig. 6. A. Effect of a 30 mm exposure of HPMC to CAPD 2 () or BIC 20() followed by an in vitro recovery period on cellular A TP levels. Data are
presented as % of control ATP levels (M199) from 5 separate HPMC
preparations. *Statistically significant difference (P < 0.05) compared to
control HPMC ATP levels; lines represent a statistically significant
difference between BIC 20 and CAPD 2 (P < 0.05). B. Effect of 30
minutes of exposure of HPMC to CAPD 3 or BIC 30 followed by an in
vitro recovery period on cellular ATP levels. Data are presented as % of
control ATP levels (M199) from 5 separate HPMC preparations. *Statis
tically significant difference (P < 0.05) compared to control HPMC ATP
levels; lines represent a statistically significant difference between BIC 30
and CAPD 3 (P < 0.05). C. Effect of 30 minutes of exposure of HPMC to
BIC 20 () or BIC 30 () followed by an in vitro recovery period on
cellular ATP levels. Data are presented as % of control ATP levels
(M199) from 5 separate HPMC preparations. *Statistically significant
difference compared to control HPMC ATP levels between BIC 20 and
BIC 30 (P < 0.05).
5.03 pg/xg cell protein (26% inhibition, N = 6, z = 2.023; P <
0.02 vs. stimulated control). Increasing the pre-exposure period to
30 minutes increased this inhibitory effect (27.6 7.6 pg/rg cell
protein, 36.7%% inhibition, N = 6, z = 2.023; P < 0.02 vs.
stimulated control; Fig. 7B). Exposure of HPMC to BIC 30 or
CAPD 3 at pH 7.3 resulted in a normalization of HPMC
stimulated IL-6 synthesis (Fig. 7B).
In all cases exposure of HPMC to CAPD 2 or CAPD 3 at pH
5.5 (for 15 or 30 mm) resulted in a significantly lower stimulated
IL-6 synthesis compared to the respective bicarbonate buffered
PDF (N = 6, z = 2.023, P < 0.02 for all). In these experiments
there was no difference between exposure to BIC 20 and BIC 30.
Expression of IL-6 mRNA following PDF exposure
Interleukin-1/3 stimulated IL-6 mRNA expression was assessed
in HPMC pre-exposed for 15 minutes to BIC 20, BIC 30 or
control medium. Following stimulation IL-6 mRNA levels were
increased in a time dependent manner after all treatments. There
did not, however, appear to be any difference in the level of IL-6
mRNA expression irrespective of pre-treatment regimen (Fig. 8).
Discussion
The long-term success of peritoneal dialysis is limited by the
lifespan of the peritoneal membrane as a successful dialyzing
organ. While it is clear that repeated episodes of peritonitis may
significantly affect the structure of the peritoneum, it is equally
clear that alterations in the peritoneal membrane can also occur in
patients without a history of infection 29, 30]. The mesothelium
lining the peritoneal membrane is repeatedly exposed to PDF
during CAPD and alterations in mesothelial cell morphology
following exposure to PDF have been documented both in vivo
and in vitro [31—34]. Although the process whereby membrane
function is modified or lost is incompletely understood, it is clear
that repeated acute exposure to unphysiological PDF may be an
important contributory element.
Repeated exposure to PDF might also compromise the host's
resistance to infection, since peritoneal leukocytes are assumed to
be the first line of host defence in the peritoneum [35, 36], and the
clearance of bacteria from the infected peritoneum is facilitated
by infiltrating leukocytes [37J.
In the present study we evaluated the biocompatibility profile of
a newly formulated PDF containing bicarbonate as a buffer and
compared it to conventional lactate buffered solutions. We have
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Fig. 7. A. Effect of acute exposure (15 or 30 mm) of HPMC to M199, BIC
20, CAPD 2 pH 5.2 or CAPD 2 pH 7.3 on their ability to synthesize IL-6 in
response to IL-Ip during an 18 hours in vitro recovery period. Data
presented are from 6 separate experiments with HPMC prepared from
separate omental specimens. **p < 0.05 versus unstimulated control; *p
< 0.05 versus M199. Symbols are: (LI) unstimulated control; () BIC 20;
(U) CAPD 2, pH 7.3; () M199 + IL-I /3; () CAPD 2, pH 5.5. B. Effect
of acute exposure (15 or 30 mm) of HPMC to M199, BIC 30, CAPD 3 pH
5.2 or CAPD 3 pH 7.3 on their ability to synthesize IL-6 in response to
IL-1/3 during an 18 hours in vitro recovery period. The data presented are
from 6 separate experiments with HPMC prepared from separate omental
specimens. P < 0.05 versus unstimulated control; * < 0.05 versus
M199. Symbols are: (LI) unstimulated control; () BIC 30; (LI) CAPD 3,
pH 7.3; (fl) M199 + IL-1/3; (LI) CAPD 3, pH 5.5.
evaluated the effects of these solutions on the phagocyte as well
on mesothelial cell viability and function. In addition, we have
assessed their ability to support the survival of common peritoneal
pathogens.
In many previous biocompatibility studies authors have used
"static" experimental systems, with prolonged (unphysiological)
exposure periods to assess PDF biocompatibility 1381. It is well
established, however, that following infusion, lactate buffered
PDF is equilibrated rapidly in vivo. Its initial pH (5.2 to 5.5) rises
within the first 20 to 30 minutes, and its lactate concentration and
osmolality decrease with increasing dwell time [39]. As a result of
this it has been recently suggested that the rapid equilibration of
PDF in vivo, together with the protective effect of the protein-rich
residual fluid volume, has little effect on cell functions in vivo [40].
Data from the group of de Fijter [14, 41, 42], however, clearly
demonstrate that the inhibitory components delineated in vitro,
viz, pH/lactate and high glucose/osmolality have inhibitory effects
on peritoneal macrophage function. These effects, including re-
ductions in phagocytic and killing capacity, were evident even
after a 60 to 90 minute dwell period in vivo, by which time the
infused PDF would be equilibrated [14, 42]. These observations
suggest that inhibitory effects do occur in vivo and indicate that
even short term exposure to PDF may be sufficient to modulate
cell function despite the equilibration process.
During CAPD the peritoneal membrane and the resident
phagocytes of the peritoneal cavity are repeatedly acutely exposed
to the inhibitory effects of PDF. Unlike infiltrating leukocytes, the
mesothelium is not continuously replenished with new cells during
a normal dwell period. The mesothelium therefore represents a
major target for the repeated inhibitory effects of acute exposure
to PDF. As a result of this and in order to simulate the in vivo
situation, in the present study, we have chosen to expose PMN
and HPMC acutely to PDF (15 to 30 mm exposure) and assess cell
function during or after an in vitro recovery period in control
medium.
Exposure of PMN and HPMC to lactate buffered PDF at pH
5.2 resulted in significant modulation of cellular ATP content as
well as significant reductions in cell functional parameters, con-
firming our recent observations [21]. In contrast, exposure of cells
to bicarbonate buffered PDF resulted in an improvement of all
cell functions compared to lactate buffered PDF. In low glucose
solutions (BIC 20) many functions were restored to control values.
In high glucose fluids (both lactate and bicarbonate buffered
PDF), the inhibition of STZ phagocytosis by PMN, a function
known to be particularly affected by high glucose/osmolality,
remained evident [81. Phagocytic function in bicarbonate buffered
PDF was however, significantly better than in lactate buffered
PDF, irrespective of the initial pH. These data suggest that, while
the use of a bicarbonate buffer reduces the inhibitory effects
associated with low pH and lactate concentration [91, the inhibi-
tory effects associated with high glucose are still evident [4, 81.
Interestingly, PMN ATP levels and the phagocytosis of zymosan
were significantly better in high glucose bicarbonate buffered PDF
(BIC 30) compared to lactate buffered PDF at neutral pH (CAPD
3 at pH 7.3). These data suggest that in addition to the effects
mediated by glucose per se, effects mediated by the presence of
lactate are manifest in this system. Such differences were not,
however, manifest in HPMC cytokine synthesis following expo-
sure to identical solutions.
We have previously observed inhibition of steady-state mRNA
levels for cytokines in mononuclear cells or HPMC acutely
exposed to lactate buffered PDF [15, 21], and suggested this as
one mechanism by which PDF exert their inhibitory effects.
Exposure of HPMC to bicarbonate buffered PDF, irrespective of
glucose content, did not modulate the IL-1/3 induced increase in
lL-6 mRNA nor did it affect IL-6 secretion. These observations
confirm that the improved biocompatibility of bicarbonate buff-
ered PDF for HPMC is related to its lack of effect on the signal
transduction mechanisms required for IL-6 synthesis.
The lack of effect of BIC 30 on HPMC IL-6 synthesis and
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mRNA expression contrasts with our previous study in peripheral
blood mononuclear cells (PBMC) in which BIC 30 down-regu-
lated both IL-6 and TNFr at both the protein and mRNA level
[151. In these previous experiments, however, PBMC were ex-
posed to fluids for two hours prior to assessment of cell function,
and thus the effects of hyperosmolality on cell function may have
been more manifest in this extended exposure system, rather than
in our HPMC acute exposure model. In this respect, PBMC
cytokine synthesis appears to be particularly sensitive to the
effects of increasing osmolality [8].
One mechanism by which lactate buffered PDF exerts its
inhibitory effects appears to be related to the rapid lowering of
intracellular pH [9, 43, 44] that occurs in the presence of lactate
(and other organic acids) at low external pH. In the present study,
both low and high glucose lactate buffered PDF, rapidly lowered
PMN [pH]1 confirming previous observations. In contrast, expo-
sure to bicarbonate buffered PDF had little effect on intracellular
acidification irrespective of its glucose concentration. It has
previously been demonstrated [45] that exposure of human plate-
lets to sodium bicarbonate caused a lowering of [pHI1. The
authors concluded that this occurs as a result of the formation of
carbonic acid by combination of bicarbonate with H ions. The
contrast with the present results remains unclear, although in the
present study we used a pre-mixed bicarbonate solution rather
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Fig. 8. Effect of 15 minutes of exposure to M199, BIC 20 or BIC 30 on the ability of IL -1 /3 to stimulate an increase in IL-6 mRNA. Data are presented,
from a representative experiment of three, as the negative of an ethidium bromide stained gel (A), and the data derived from densitometric scanning
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Topley et al: Cell function in bicarbonate dialysis fluids 1455
than adding sodium bicarbonate to Tyrode's buffer. It does not
appear, however, that the effect described is occurring within our
system. The pH of both BIC 20 and BIC 30 remained stable in our
experimental system for up to six hours, suggesting that diffusion
of CO2 was not a problem, especially as the [pH]1 measurements
were performed over a maximum of six minutes.
We have previously observed that cellular ATP levels are
rapidly and reversibly lowered in HPMC acutely exposed to
lactate buffered PDF at pH 5.2 [21]. This effect occurs within
minutes and led to the proposal that lowering of {pH] might be
responsible for the observed drop in cellular ATP levels. In the
present study, HPMC ATP levels were also reduced following
exposure to BIC 30, suggesting that lowering of [pH]1 might not be
the only mechanism by which cellular ATP levels can be depleted,
although the most profound drop in both occurs in the presence
of lactate at low external pH.
Another consideration when redesigning more physiological
dialysis fluids is their ability to support bacterial survival, and
previous studies have suggested that improving the biocompatibil-
ity of PDF might be associated with increased bacterial survival
[121. It is well known that Staphylococci are unable to grow in
lactate buffered PDF [46, 47]. In the present study the viable
counts of both S. epidermidis and S. aureus were significantly
reduced in both bicarbonate and lactate buffered PDF irrespective
of glucose content, In experiments performed with PDF buffered
with histidine to increase its initial pH to 6,7 and improve its in
vitro biocompatibility, the survival of Staphylococci was increased.
These data suggest that the added histidine, rather than the
increased pH per Se, was responsible for the increased bacterial
survival. Neutral pH bicarbonate buffered PDF (irrespective of
glucose content) do not appear to provide an advantage for
bacterial survival under these conditions,
It is now clear that the peritoneal membrane and the mesothe-
hum in particular contributes significantly to the control of
inflammation within the peritoneal cavity. This it achieves via the
secretion of vasoactive prostaglandins, pro- and immunomodula-
tory cytokines as well as chemokines important in the recruitment
of leukocytes during infection [20, 22, 48—51]. The modulation of
these tightly controlled processes, as well as alterations in the
structure of the peritoneal membrane by repeated acute exposure
to unphysiological PDF may be detrimental to its prescribed
function as a dialyzing organ. Redesign of PDF utilizing bicar-
bonate as a buffer and thus creating a less inhibitory pH neutral
solution may better preserve the long term function of the
peritoneal membrane.
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Appendix
Abbreviations are: CAPD, continuous ambulatory peritoneal dialysis;
FCS, total calf serum; IL-6, interleukin-6; RT!PCR, reverse transcription!
polymerase chain reaction; HPMC, human peritoneal mesothelial cell;
PDF, peritoneal dialysis fluid; IL-1f3, interleukin-1f3; ELISA, enzyme
linked immunoassay; PMN, human neutrophil; [pH]1, intracellular pH.
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